Early and sustained improvements in patient-reported outcomes with tralokinumab in combination with topical corticosteroids as needed in moderate-to-severe atopic dermatitis

被引：0
|
作者：
Elewski, B. E. [1 ]
Staender, S. [2 ,3 ]
Zirwas, M. [4 ]
Silvestre, J. F. [5 ]
Kalia, S. [6 ,7 ,8 ]
Gutermuth, J. [9 ,10 ]
Mark, T. [11 ]
Tindberg, A. M. [11 ]
Silverberg, J. I. [12 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Univ Hosp Munster, Dept Dermatol, Munster, Germany
[3] Univ Hosp Munster, Interdisciplinary Competence Ctr Chron Pruritus K, Munster, Germany
[4] Prob Med Res, Columbus, OH USA
[5] Hosp Gen Univ Alicante, Dermatol Dept, Alicante, Spain
[6] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC, Canada
[7] Vancouver Coastal Hlth, Vancouver, BC, Canada
[8] BC Childrens Hosp Res Inst, Vancouver, BC, Canada
[9] Univ Ziekenhuis Brussel, Dept Dermatol, Brussels, Belgium
[10] Vrije Univ Brussel, Brussels, Belgium
[11] LEO Pharma AS, Ballerup, Denmark
[12] George Washington Univ, Sch Med & Hlth Sci, Depat Dermatol, Washington, DC 20052 USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2021年 / 184卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
385
引用
收藏
页码：E83 / E84
页数：2
相关论文
共 50 条
  • [1] Progressive and sustained improvements in the extent and severity of atopic dermatitis with tralokinumab in combination with topical corticosteroids as needed in moderate-to-severe atopic dermatitis
    Alexis, A. F.
    Zirwas, M.
    Pinter, A.
    Adam, D. N.
    Chiricozzi, A.
    Pink, A. E.
    Mark, T.
    Tindberg, A. M.
    Silverberg, J. I.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (03) : E82 - E83
  • [2] TRALOKINUMAB IN COMBINATION WITH AS-NEEDED TOPICAL CORTICOSTEROIDS PROVIDES SUSTAINED IMPROVEMENTS IN ITCH AND SLEEP IN MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Elewski, Boni E.
    Stander, Sonja
    Zirwas, Matthew
    Silvestre, Juan Francisco
    Kalia, Sunil
    Gutermuth, Jan
    Mark, Thomas
    Tindberg, Ann-Marie
    Silverberg, Jonathan I.
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 64 - 64
  • [3] TRALOKINUMAB PLUS TOPICAL CORTICOSTEROIDS AS NEEDED PROVIDES PROGRESSIVE IMPROVEMENTS IN EXTENT AND SEVERITY OF MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Alexis, Andrew F.
    Zirwas, Matthew
    Pinter, Andreas
    Adam, David N.
    Chiricozzi, Andrea
    Pink, Andrew E.
    Mark, Thomas
    Tindberg, Ann-Marie
    Silverberg, Jonathan I.
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 63 - 64
  • [4] Tralokinumab treatment substantially improves patient-reported outcomes in adolescents with moderate-to-severe atopic dermatitis at 16 weeks
    Soong, Weily
    Blauvelt, Andrew
    Wollenberg, Andreas
    Hong, H. Chih-ho
    Leflein, Jeffrey
    Bewley, Anthony
    Amoudruz, Petra
    Moerch, Marie Holst
    Soldbro, Lise
    Schneider, Shannon
    Simpson, Eric L.
    Paller, Amy
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E91 - E92
  • [5] The impact of severity of atopic dermatitis on patient-reported outcomes of adults with moderate-to-severe atopic dermatitis
    Vietri, Jeffrey
    Nyberg, Fredrik
    Varol, Nebibe
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB254 - AB254
  • [6] Lebrikizumab Combined with Topical Corticosteroids Improves Patient- reported Outcomes in Japanese Patients with Moderate-to-severe Atopic Dermatitis
    Tanaka, Akio
    Igawa, Ken
    Takahashi, Hidetoshi
    Shimizu, Ryosuke
    Kataoka, Yoko
    Torisu-Itakura, Hitoe
    Morisaki, Yoji
    Montmayeur, Sonia
    Katoh, Norito
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [7] Is antibiotics prescription needed in infants with topical corticosteroids treatment for moderate-to-severe atopic dermatitis?
    Liu, Ying
    Zhou, Qian
    Dai, Wenkui
    Wang, Shan
    Liang, Yuan
    Li, Yinhu
    Shen, Chunping
    Li, Dongfang
    Li, Yunzhu
    Jiao, Lei
    Bian, Yawei
    Li, Shuaicheng
    Tang, Yi-Wei
    Ma, Lin
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [8] Effectiveness and Safety of Upadacitinib in Combination with Topical Corticosteroids in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
    Hagino, Teppei
    Hamada, Risa
    Yoshida, Mai
    Fujimoto, Eita
    Saeki, Hidehisa
    Kanda, Naoko
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2023, 16 : 3201 - 3212
  • [9] Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis
    Edwards, Steven J.
    Karner, Charlotta
    Jhita, Tracey
    Barton, Samantha
    Marceniuk, Gemma
    Yiu, Zenas Z. N.
    Wittmann, Miriam
    HEALTH TECHNOLOGY ASSESSMENT, 2024, 28 (04)
  • [10] 497-Lebrikizumab in combination with topical corticosteroids maintains improvements in itch and sleep at 68 weeks in patients with moderate-to-severe atopic dermatitis
    Yosipovitch, Gil
    Lio, Peter A.
    Rosmarin, David
    Casillas, Marta
    Yang, Fan Emily
    Hu, Chaoran
    Pierce, Evangeline
    Legat, Franz J.
    Carrascosa, Jose-Manuel
    Crane, Heidi
    Boncompte, Laia
    Stander, Sonja
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II6 - II7
12345